On the recordJuly 24, 1996
many people, and there is no disagreement in this Chamber that the substance of what the gentleman from Iowa [Mr. Ganske] is trying to do makes a lot of sense, but as has been pointed out by a number of colleagues, and I will reiterate and focus in on it, there are clearly cases where the language of this amendment is broader than the intent. It will absolutely include certain biotechnology therapies that were under development that already exist. Whether we like it or not, the companies that do this invest sometimes tens and even hundreds of millions of dollars. If they cannot be provided with a patent for that protection, they just will not develop those lifesaving drugs. I urge the defeat of the Ganske amendment.
Source
govinfo.gov
